Working capacity is increased following recombinant human erythropoietin treatment
- 1 October 1988
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 34 (4), 525-528
- https://doi.org/10.1038/ki.1988.213
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis.BMJ, 1987
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- EFFECT OF HUMAN ERYTHROPOIETIN DERIVED FROM RECOMBINANT DNA ON THE ANAEMIA OF PATIENTS MAINTAINED BY CHRONIC HAEMODIALYSISThe Lancet, 1986
- The anemia of chronic renal failure in sheep. Response to erythropoietin-rich plasma in vivo.JCI Insight, 1984
- Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiencyKidney International, 1984
- The metabolic and psychological effects of exercise training in hemodialysis patientsThe American Journal of Clinical Nutrition, 1980
- Anaerobic threshold and respiratory gas exchange during exercise.Journal of Applied Physiology, 1973